Dr. Miao Wang will give us a talk on the importance of translational medicine in modern drug discovery.
Prostanoids are a class of small lipid molecules with diverse physiological and pathological function. They are synthesized from cell membrane-released arachidonic acid under sequential enzymatic actions. Cyclooxigenases (COXs) are rate-limiting enzyme in the biosynthesis and are targeted by non-steroidal anti-inflammatory drugs (NSAIDs), like aspirin and ibuprofen. Efficacy and toxicity consideration has been driving drug discovery of new NSAIDs. As such, COX-2 selective inhibitors were developed, however, recent clinical trials show increased cardiovascular toxicity is associated with these drugs. The function of prostanoids in cardiovascular system will be discussed, with particular focus on a new drug target in the COX pathway.
Hope to see you at CRB 302, 12:00 - 1:30 PM on Wednesday (July 30, 2008)! Snacks and water are provided. Lunch boxes are welcome.
Ms. Yao Zhang, a PhD candidate in the Department of Chemistry at UPenn, will talk about
